6-116732074-TTATATATATATATATATATATATATATATATATATATATATA-TTATATATATATATATATATATATATATATATATATATATATATATATA

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_001366306.2(KPNA5):​c.1433-19_1433-14dupTATATA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 67,242 control chromosomes in the GnomAD database, including 89 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.021 ( 89 hom., cov: 12)
Exomes 𝑓: 0.00072 ( 0 hom. )

Consequence

KPNA5
NM_001366306.2 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00

Publications

3 publications found
Variant links:
Genes affected
KPNA5 (HGNC:6398): (karyopherin subunit alpha 5) The transport of molecules between the nucleus and the cytoplasm in eukaryotic cells is mediated by the nuclear pore complex (NPC) which consists of 60-100 proteins and is probably 120 million daltons in molecular size. Small molecules (up to 70 kD) can pass through the nuclear pore by nonselective diffusion; larger molecules are transported by an active process. Most nuclear proteins contain short basic amino acid sequences known as nuclear localization signals (NLSs). KPNA5 protein belongs to the importin alpha protein family and is thought to be involved in NLS-dependent protein import into the nucleus. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001366306.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High Homozygotes in GnomAd4 at 89 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001366306.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KPNA5
NM_001366306.2
MANE Select
c.1433-19_1433-14dupTATATA
intron
N/ANP_001353235.1O15131
KPNA5
NM_001366304.1
c.1493-19_1493-14dupTATATA
intron
N/ANP_001353233.1A0A8V8TMV2
KPNA5
NM_001366305.2
c.1493-19_1493-14dupTATATA
intron
N/ANP_001353234.1A0A8V8TMV2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KPNA5
ENST00000368564.7
TSL:1 MANE Select
c.1433-62_1433-61insTATATA
intron
N/AENSP00000357552.1O15131
KPNA5
ENST00000356348.6
TSL:1
c.1433-62_1433-61insTATATA
intron
N/AENSP00000348704.1O15131
KPNA5
ENST00000937498.1
c.1508-62_1508-61insTATATA
intron
N/AENSP00000607557.1

Frequencies

GnomAD3 genomes
AF:
0.0205
AC:
952
AN:
46432
Hom.:
89
Cov.:
12
show subpopulations
Gnomad AFR
AF:
0.00886
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.0234
Gnomad SAS
AF:
0.0146
Gnomad FIN
AF:
0.00668
Gnomad MID
AF:
0.0179
Gnomad NFE
AF:
0.0293
Gnomad OTH
AF:
0.0194
GnomAD4 exome
AF:
0.000721
AC:
15
AN:
20808
Hom.:
0
AF XY:
0.00102
AC XY:
12
AN XY:
11796
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
956
American (AMR)
AF:
0.00
AC:
0
AN:
720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
974
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1048
South Asian (SAS)
AF:
0.000613
AC:
1
AN:
1632
European-Finnish (FIN)
AF:
0.00195
AC:
7
AN:
3584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
64
European-Non Finnish (NFE)
AF:
0.000645
AC:
7
AN:
10848
Other (OTH)
AF:
0.00
AC:
0
AN:
982
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0000000000307979), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.292
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0205
AC:
952
AN:
46434
Hom.:
89
Cov.:
12
AF XY:
0.0203
AC XY:
434
AN XY:
21328
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00885
AC:
128
AN:
14466
American (AMR)
AF:
0.0167
AC:
77
AN:
4612
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
51
AN:
1404
East Asian (EAS)
AF:
0.0237
AC:
33
AN:
1392
South Asian (SAS)
AF:
0.0146
AC:
21
AN:
1438
European-Finnish (FIN)
AF:
0.00668
AC:
7
AN:
1048
Middle Eastern (MID)
AF:
0.0192
AC:
1
AN:
52
European-Non Finnish (NFE)
AF:
0.0293
AC:
622
AN:
21260
Other (OTH)
AF:
0.0193
AC:
12
AN:
622
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.377
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
BranchPoint Hunter
2.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2243369;
hg19: chr6-117053237;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.